Nivedita Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.25 M
as on 17-06-2024
- Paid Up Capital ₹ 0.12 M
as on 17-06-2024
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 41.95 Cr
as on 17-06-2024
- Revenue 9.50%
(FY 2022)
- Profit 41.82%
(FY 2022)
- Ebitda 392.70%
(FY 2022)
- Net Worth -2.30%
(FY 2022)
- Total Assets 25.89%
(FY 2022)
About Nivedita Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.25 M and a paid-up capital of Rs 0.12 M.
The company currently has active open charges totaling ₹41.95 Cr.
Anuj Goyal and Ritu Agarwal serve as directors at the Company.
- CIN/LLPIN
U74900DL2011PTC225928
- Company No.
225928
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 2011
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nivedita Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anuj Goyal  | Director | 16-Nov-2015 | Current |
| Ritu Agarwal | Director | 07-Oct-2011 | Current |
Financial Performance and Corporate Structure Insights of Nivedita Pharma.
Nivedita Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.5% increase. The company also saw a substantial improvement in profitability, with a 41.82% increase in profit. The company's net worth dipped by a decrease of 2.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nivedita Pharma?
In 2022, Nivedita Pharma had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Riddhish Agri Products Private LimitedActive 29 years 9 monthsAnuj Goyal and Ritu Agarwal are mutual person
- Nandgaon Agri Research & Developements Private LimitedActive 9 years 6 months
Anuj Goyal and Ritu Agarwal are mutual person
- Farmjoy Crop Research Private LimitedActive 9 years 4 months
Anuj Goyal and Ritu Agarwal are mutual person
- Kartikeya Shelters Private LimitedActive 16 years 9 months
Anuj Goyal and Ritu Agarwal are mutual person
- Lefin (India) Private LimitedActive 29 years 11 months
Anuj Goyal and Ritu Agarwal are mutual person
- Pratibha Consultants Private LimitedActive 16 years 4 months
Anuj Goyal and Ritu Agarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Feb 2024 | ₹8.00 M | Open |
Others Creation Date: 06 Jan 2024 | ₹3.50 Cr | Open |
Others Creation Date: 08 Nov 2023 | ₹3.70 Cr | Open |
How Many Employees Work at Nivedita Pharma?
Unlock and access historical data on people associated with Nivedita Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nivedita Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nivedita Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
